NL-OMON20034
Completed
Not Applicable
Follow-up of thrombophilia, inflammation and markers of cardiovascular disease in HIV-1 patients on long-term cART
none0 sites39 target enrollmentTBD
ConditionsHIV, thrombophilia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- HIV, thrombophilia
- Sponsor
- none
- Enrollment
- 39
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion in the original INF\-BEAST study
Exclusion Criteria
- •Declining informed consent to participate in the INF\-BEAST2 study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Follow-up of thrombophilia, inflammation and markers of cardiovascular disease of HIV-1 patients on longterm cARTNL-OMON47997niversitair Medisch Centrum Groningen39
Completed
Not Applicable
Thrombofilia, inflammation and markers of cardiovascular disease in HIV-1 infected patientscoagulation factorsvenous thrombosis100644771004743810014523NL-OMON34363niversitair Medisch Centrum Groningen40
Completed
Phase 2
Platenza Tablets for Dengue feverCTRI/2018/02/011789The Himalaya Drug Company40
Recruiting
Not Applicable
Bleeding and thromboembolic complications following Fontan operation: a single center retrospective cohort studyThromboembolic complications following Fontan operation were 8% -25%.It was associated with late death in 10-25% of Fontan patientsBleedingThromboembolic eventsFontan operationTCTR20220506008/A126
Completed
Phase 2
Platenza Tablets for Dengue feverHealth Condition 1: null- Dengue FeverCTRI/2018/03/012738The Himalaya Drug Company60